Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 29 most recent Form 4 transactions.
| $26.1K |
| -0.4% |
| Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,600 | $63.69 | $101.9K | -1.6% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 17,284 | $62.62 | $1.1M | -14.4% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 25,390 | $62.02 | $1.6M | -17.5% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 32,395 | $8.93 | $289.3K | +28.7% | Open the original filing on SEC.gov |
| Jun 22 | TVTX | Travere Therapeutics, Inc. | GGIFT | 468 | — | — | -0.4% | Open the original filing on SEC.gov |
| May 6 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 311 | $43.95 | $13.7K | -0.3% | Open the original filing on SEC.gov |
| May 5 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 2,174 | $46.65 | $101.4K | -1.9% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,250 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | AGRANT◷◆ | 8,500 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,250 | — | — | +3.8% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 20,000 | $45.00 | $900K | -15.2% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 20,000 | $22.40 | $448K | +17.9% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,018 | $42.61 | $43.4K | -0.9% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 7,215 | $41.93 | $302.5K | -6.0% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | AGRANT◷ | 14,000 | — | — | +13.2% | Open the original filing on SEC.gov |
| Feb 4 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 232 | $32.85 | $7.6K | -0.2% | Open the original filing on SEC.gov |
| Feb 4 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,547 | $32.11 | $49.7K | -1.4% | Open the original filing on SEC.gov |
| Feb 3 | TVTX | Travere Therapeutics, Inc. | SSELL | 6,956 | $32.12 | $223.4K | -6.1% | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 75,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT | 28,130 | — | — | +32.6% | Open the original filing on SEC.gov |
| Jan 6 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 445 | $37.75 | $16.8K | -0.5% | Open the original filing on SEC.gov |
| Jan 5 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 2,031 | $40.18 | $81.6K | -2.3% | Open the original filing on SEC.gov |
| Dec 24, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 24, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 15,000 | $42.00 | $630K | -14.4% | Open the original filing on SEC.gov |
| Dec 24, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 15,000 | $8.93 | $134K | +16.9% | Open the original filing on SEC.gov |
| Jul 1, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 815 | $14.65 | $11.9K | -0.9% | Open the original filing on SEC.gov |